1-2 of 2
Xianfeng Zhao, MD, PhD
Close
Sort by
Journal Articles

c-MYC Drives PBK Expression in High-Grade Malignant Lymphomas Through E2F1

Fang Hu, Xianfeng Zhao, MD, PhD, Hongbin Fang, PhD, Ronald Gartenhaus, Poss Elise Daniela, Aaron P. Rapoport, MD
Journal: Blood
Blood (2011) 118 (21): 1569.
https://doi.org/10.1182/blood.V118.21.1569.1569
Published: 2011
Journal Articles

Clinical Impact of TP53 Gene Mutations in Diffuse Large B-Cell Lymphoma (DLBCL): An International DLBCL Rituxan-CHOP Consortium Program Study.

Ken H. Young, MD, PhD, Nancy Patten, PhD, Sim Truong, PhD, Jens Eickhoff, PhD, Gabrielle L. Rocque, MD, Jeffrey T. Malik, MD, Yan Li, PhD, Kazunori Kanehira, MD, PhD, Matthew Twohig, MD, William M. Rehrauer, PhD, Michelle A. Waknitz, MS, Brad S. Kahl, MD, Michael B. Moller, MD, PhD, Alexander Tzankov, PhD, Santiago M. Moreno, MD, Miguel A. Piris, MD, Carlo Visco, MD, Karen Dybkaer, PhD, April Chiu, MD, Attilio Orazi, MD, Jeff C. Chang, MD, PhD, Govind Bhagat, MD, Jane N. Winter, MD, Huan-You Wang, MD, PhD, Cherie Dunphy, MD, Stacey O'Neill, MD, PhD, Eric D. Hsi, MD, Xianfeng Zhao, MD, PhD, Kristin Hunt, MD, Weina Chen, MD, PhD, Ronald S. Go, MD, William W.L. Choi, MD, Fan Zhou, MD, PhD, Magdalena Czader, MD, PhD, Yong Li, PhD, Suzanne Selvaggi, MD, James S. Malter, MD, Lin Wu, PhD
Journal: Blood
Blood (2009) 114 (22): 967.
https://doi.org/10.1182/blood.V114.22.967.967
Published: 2009